Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 4 1Phase 2 1

Status

Completed 3Terminated 2

Sponsor Class

OTHER 3INDUSTRY 2

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 4Dermatologic 1Breast 1

Conditions

Stomach Neoplasms 2Colonic Neoplasms 2Keratosis, Actinic 1Colonic Polyps 1Breast Neoplasms 1

Interventions

Cisplatin 3193Cyclophosphamide 3187Carboplatin 2968Radiotherapy 2784Paclitaxel 2716Gemcitabine 2569pembrolizumab 2378Bevacizumab 2206Docetaxel 2196Fluorouracil 1848Capecitabine 1828Oxaliplatin 1738Dexamethasone 1604Nivolumab 1580Doxorubicin 1501Rituximab 1487Magnetic Resonance Spectroscopy 1382Etoposide 1345Irinotecan 1245Leucovorin 1222Drug Therapy 1202Cytarabine 1130Pemetrexed 1074fludarabine 1056Specimen Handling 1009Vincristine 964Cetuximab 943Prednisone 940Trastuzumab 940Lenalidomide 937

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Menthol × Clear all
NCT01855607 2024-07-11

Topical Menthol for the Treatment of Chemotherapy Induced Peripheral Neuropathy

Columbia University

Phase 2 Terminated
12 enrolled 5 charts
BreastGastrointestinal

Breast Neoplasms, Colonic Neoplasms

NCT02588248 2022-04-19

MINT-C

University Hospitals Cleveland Medical Center

Phase 3 Terminated
82 enrolled 10 charts
Gastrointestinal

Colonic Neoplasms, Colonic Polyps

NCT02984072 2021-03-09

MentholPDT

University of Dundee

Phase 4 Completed
10 enrolled
Dermatologic

Keratosis, Actinic

NCT01411176 2012-06-29

Phase III Study of NPO-11 in Patients Undergoing Therapeutic Upper Gastrointestinal Endoscopy

Nihon Pharmaceutical Co., Ltd

Phase 3 Completed
85 enrolled
Gastrointestinal

Stomach Neoplasms

NCT01411189 2012-06-29

Phase III Open-labeled Study of NPO-11 in Patients Undergoing Therapeutic Upper Gastrointestinal Endoscopy

Nihon Pharmaceutical Co., Ltd

Phase 3 Completed
33 enrolled
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡